Northwestern Doc Says AbbVie's Androgel Has Heart Risks

A cardiologist who teaches at Northwestern University was called to the stand Thursday during the fourth day of a bellwether trial against AbbVie Inc. to testify about his belief that testosterone...

Already a subscriber? Click here to view full article